Did more high-dose vitamin B1 help patients with alcohol-related brain damage?

Wernicke encephalopathy is a medical emergency where a severe lack of vitamin B1 damages the brain, often in people with alcohol use disorder. If not treated quickly and properly, it can lead to lasting disability or death. A new look at hospital records in Japan reveals a major shift in how doctors are trying to fight it: the use of high-dose thiamine injections at the start of treatment jumped from about 5% of patients to nearly half over a 13-year period. The study followed over 7,800 patients hospitalized with the condition. Treatment started quickly, typically on the first day. Yet, the findings are sobering. More than half of the patients—56%—were discharged with impaired abilities to care for themselves, like bathing or walking. The in-hospital death rate was 3.8%. It’s important to understand what this data can and cannot tell us. This was an observational study, meaning it described what happened in real-world practice. It did not compare different doses to see which one worked better or was safer. So, while it shows a clear trend toward using more thiamine, we don’t yet know if that higher dose is the right answer for improving a patient’s long-term function. The high rate of disability at discharge highlights how devastating this condition remains and signals a critical need for more research into the best treatment and prevention strategies.